Curis
CRIS
#10201
Rank
ยฃ13.1 M
Marketcap
ยฃ1.01
Share price
0.00%
Change (1 day)
-67.27%
Change (1 year)

Revenue for Curis (CRIS)

Revenue in 2025 (TTM): ยฃ8.87 Million

According to Curis's latest financial reports the company's current revenue (TTM ) is ยฃ8.74 Million. In 2024 the company made a revenue of ยฃ8.69 Million an increase over the revenue in the year 2023 that were of ยฃ7.86 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Curis from 2001 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ8.87 M2.07%
2024 ยฃ8.69 M10.49%
2023 ยฃ7.86 M-6.34%
2022 ยฃ8.39 M6.47%
2021 ยฃ7.88 M-0.75%
2020 ยฃ7.94 M4.19%
2019 ยฃ7.62 M-7.13%
2018 ยฃ8.21 M12.17%
2017 ยฃ7.32 M20.06%
2016 ยฃ6.1 M14.74%
2015 ยฃ5.31 M-15.91%
2014 ยฃ6.32 M-30.48%
2013 ยฃ9.09 M-13.39%
2012 ยฃ10.5 M10.56%
2011 ยฃ9.49 M-8.36%
2010 ยฃ10.36 M95.25%
2009 ยฃ5.3 M-7.01%
2008 ยฃ5.7 M-30.8%
2007 ยฃ8.24 M8.19%
2006 ยฃ7.62 M15.44%
2005 ยฃ6.6 M156.04%
2004 ยฃ2.57 M-58.23%
2003 ยฃ6.17 M-46.15%
2002 ยฃ11.46 M1430.59%
2001 ยฃ0.74 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Exelixis
EXEL
ยฃ1.71 B 19,541.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.56 B 6,343.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
ยฃ19.31 M 120.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ1.95 M-77.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.13 B 538,835.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ36.05 B 412,209.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA